Homepage4DX • ASX
add
4DMedical Ltd
Vorige slotkoers
$Â 3,21
Dag-range
$Â 3,28 - $Â 3,74
Jaar-range
$Â 0,23 - $Â 5,42
Beurswaarde
2,10Â mld. AUD
Gem. volume
7,39Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
ASX
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (AUD) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,48Â mln. | -0,12% |
Bedrijfskosten | 13,34Â mln. | 10,01% |
Netto inkomsten | -5,45Â mln. | 46,48% |
Netto winstmarge | -368,55 | 46,42% |
Winst per aandeel | — | — |
EBITDA | -11,80Â mln. | -10,69% |
Effectief belastingtarief | 0,86% | — |
Balans
Totale activa
Totale passiva
| (AUD) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 6,88Â mln. | -77,52% |
Totale activa | 94,81Â mln. | -21,00% |
Totale passiva | 30,58Â mln. | -37,71% |
Totaal aandelenvermogen | 64,24 mln. | — |
Uitstaande aandelen | 493,53 mln. | — |
Koers-boekwaardeverhouding | 22,93 | — |
Rendement op activa | -31,64% | — |
Rendement op kapitaal | -43,76% | — |
Kasstroom
Nettomutatie in liquide middelen
| (AUD) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -5,45Â mln. | 46,48% |
Operationele kasstroom | -10,16Â mln. | -26,04% |
Kasstroom uit beleggingen | -388,44K | -14,42% |
Kasstroom uit financiering | 6,01Â mln. | 2.670,69% |
Nettomutatie in liquide middelen | -4,54Â mln. | 47,47% |
Vrije kasstroom | -5,40Â mln. | -4,62% |
Over
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Opgericht
2013
Website
Werknemers
124